1.
Bioorg Med Chem Lett
; 20(18): 5544-7, 2010 Sep 15.
Artículo
en Inglés
| MEDLINE
| ID: mdl-20708930
RESUMEN
The discovery of a series of novel and orally efficacious type II calcimimetics, developed from the lead compound 1, is described herein. Compound 22 suppressed plasma PTH levels relative to vehicle when dosed orally in a rat pharmacodynamic model.